乳糖凝预防新生儿低血糖和神经认知功能在早期学龄:一个随机剂量试验
Xingyu Wei1, Nike Franke1, Jane M Alsweiler2
1Liggins Institute, The University of Auckland, Auckland, New Zealand, Auckland, New Zealand.
Archives of disease in childhood. Fetal and neonatal edition
|February 2, 2024
概括
新生儿的预防性德克斯特凝并没有预防学龄儿童的神经认知障碍. 然而,它在改善新生儿低血糖症风险的儿童的运动技能和认知得分方面显示出潜在的益处.
科学领域:
- 新生儿医学 新生儿医学
- 发育儿科 发育儿科
- 公共卫生 公共卫生
背景情况:
- 新生儿低血糖是风险婴儿的一个常见问题.
- 早期干预策略对于长期的神经发育结果至关重要.
- 预防性德克斯特凝在预防神经认知障碍方面的疗效需要进一步研究.
研究的目的:
- 评估不同剂量的预防性德克斯特凝对神经认知功能和健康的长期影响.
- 为了评估德克斯特凝对6-7岁的运动技能,认知能力和心脏代谢健康的影响.
- 为了确定早期德克斯特凝的使用是否会影响高危儿童的神经认知障碍的发生率.
主要方法:
- 在hPOD前随机对照试验的早期学龄期随访.
- 涉及的儿童出生时≥35周怀孕与新生儿低血糖的危险因素.
- 使用工具箱认知和运动电池评估神经认知功能,主要结果是神经认知障碍.
主要成果:
- 在德克斯特凝组和安慰剂之间,神经认知障碍率没有显著差异.
- 与安慰剂相比,接受德克斯特凝的儿童的运动损伤风险降低 (3%vs14%).
- 德克斯特凝暴露与较高的平均认知分数 (106.0与101.1) 相关.
结论:
- 预防性新生儿德克斯特凝并没有改变早期学龄期神经认知障碍.
- 德克斯特凝可能对有风险的儿童的运动和认知发育有好处.
- 需要进一步的学龄期后续研究来证实这些发现.
相关概念视频
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Insulin: Dosing Regimen and Adverse Effects
174
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174
Pathophysiology of Diabetes
940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K


